Position
Chief Executive Officer
Company
IsomAb
NottinghamBiotechnologyHealth CareTherapeuticsBiopharmaDescription
IsomAb Ltd has appointed Dr. Philip Brainin as Chief Executive Officer, who will lead the clinical development of their candidate ISM-001 for chronic stable angina. With his extensive background in clinical cardiology and research, Dr
Quick answer
IsomAb Ltd Appoints Dr. Philip Brainin as Chief Executive Officer (March 18, 2026). IsomAb is based in Nottingham, England, United Kingdom.
- Who is the new Chief Executive Officer at IsomAb?
- IsomAb named Philip Brainin Chief Executive Officer, announced March 18, 2026.
- What did IsomAb announce on March 18, 2026?
- IsomAb Ltd has appointed Dr. Philip Brainin as Chief Executive Officer, who will lead the clinical development of their candidate ISM-001 for chronic stable angina.
- What does IsomAb do?
- IsomAb Ltd is a UK-based biopharmaceutical company founded in 2022, specializing in isoform-specific disease modifying antibody treatments for serious and life-threatening diseases.
- Where is IsomAb based?
- IsomAb is based in Nottingham, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Atossa Therapeutics (March 19, 2026), Aquestive Therapeutics, Inc. (March 20, 2026), Aurinia Pharma (March 23, 2026) and Rani Therapeutics Holdings (March 25, 2026) also announced leadership changes within 45 days of IsomAb.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Atossa Therapeutics Appoints Kathy Puyana Theall and Adebola Giwa as Medical Directors (March 19, 2026)
- Aquestive Therapeutics Announces Departure of Chief Legal Officer (March 20, 2026)
- Aurinia Pharmaceuticals Appoints Kevin Tang as Chief Executive Officer and Ryan Cole as Chief Operating Officer (March 23, 2026)
- Rani Therapeutics Appoints Jesper Høiland as Head of Strategy (March 25, 2026)
- MBX Biosciences Appoints Karen Basbaum as Chief Business Officer (March 10, 2026)
- Santhera Pharmaceuticals Appoints Marc Clausse as Chief Commercial Officer (March 10, 2026)
Who to call at IsomAb, and when
A new leader at IsomAb brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day IsomAb raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IsomAb, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IsomAb. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IsomAb changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
IsomAb changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.